Overview
- Following Tuesday’s earnings release, Oklo shares fell roughly 5% to 6% as traders weighed a wider quarterly loss and higher spending at the pre‑revenue nuclear developer.
- Oklo reported a $33.1 million net loss for Q1 with no revenue, while ending the quarter with about $2.5 billion in cash and marketable securities after raising $1.2 billion through at‑the‑market share sales.
- The company filed a new $1 billion equity program to fund construction, fuel and isotope projects, a move that adds financing flexibility but could increase dilution for current shareholders.
- The Nuclear Regulatory Commission approved the Principal Design Criteria for the Aurora powerhouse at Idaho National Laboratory, a foundational safety and design step, and Oklo announced AI collaborations with Battelle/INL and with Nvidia and Los Alamos to speed modeling and documentation.
- Management reiterated key targets, including bringing the Groves isotope test reactor to criticality by July 4, 2026—when a reactor first sustains a controlled chain reaction—and aiming for first commercial operations by 2028, with site work spanning Idaho, Ohio and Alaska.